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Abstract
Maintenance of self-renewal and pluripotency in mouse embryonic stem cells (mESCs) is regulated by the balance between
several extrinsic signaling pathways. Recently, we demonstrated that heparan sulfate (HS) chains play important roles in the
maintenance and differentiation of mESCs by regulating extrinsic signaling. Sulfated HS structures are modified by various
sulfotransferases during development. However, the significance of specific HS structures during development remains
unclear. Here, we show that 3-O-sulfated HS structures synthesized by HS 3-O-sulfotransferases (3OSTs) and recognized by
the antibody HS4C3 increase during differentiation of mESCs. Furthermore, expression of Fas on the cell surface of the
differentiated cells also increased. Overexpression of the HS4C3-binding epitope in mESCs induced apoptosis and
spontaneous differentiation even in the presence of LIF and serum. These data showed that the HS4C3-binding epitope was
required for differentiation of mESCs. Up-regulation of the HS4C3-binding epitope resulted in the recruitment of Fas from
the cytoplasm to lipid rafts on the cell surface followed by activation of Fas signaling. Indeed, the HS4C3-binding epitope
interacted with a region that included the heparin-binding domain (KLRRRVH) of Fas. Reduced self-renewal capability in
cells overexpressing 3OST resulted from the degradation of Nanog by activated caspase-3, which is downstream of Fas
signaling, and was rescued by the inhibition of Fas signaling. We also found that knockdown of 3OST and inhibition of Fas
signaling reduced the potential for differentiation into the three germ layers during embryoid body formation. This is the
first demonstration that activation of Fas signaling is mediated by an increase in the HS4C3-binding epitope and indicates a
novel signaling pathway for differentiation in mESCs.
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Introduction
Heparan sulfate (HS) is a ubiquitous component of proteogly-
cans in the extracellular matrix and on the cell surface. In
proteoglycans, the HS polysaccharide chains are attached
covalently to Ser residues in the core proteins through the linkage
region GlcAb1-3Galb1-3Galb1-4Xylb1-O-Ser [1]. HS chains are
synthesized in the Golgi by several enzymes, including members of
the EXT protein family, which elongate the HS chain by adding
repeating disaccharide units of D-glucuronic acid-N-acetyl-D-
glucosamine (-4GlcAb1-4GlcNAca1-)n. These repeating units are
then modified differentially by epimerization and sulfation to
produce a wide range of structurally and functionally diverse
compounds [1]. Many molecules that are important for develop-
ment, including members of the fibroblast growth factor (Fgf)
family, Wnt, and bone morphogenic protein (BMP), can bind to
specific sulfated regions of HS chains, which regulate signaling by
these molecules [2,3]. The control of sulfated HS structures is
considered essential for the spatiotemporal regulation of cellular
differentiation and growth throughout development.
Embryonic stem cells (ESCs) [4,5] are promising tools for
biotechnology and possess key features that should allow their
exploitation in cell replacement therapies [6]. To exploit this
potential, a better understanding of the molecular mechanisms
that control ESC pluripotency is required. Pluripotency is
regulated by a combination of intrinsic and extrinsic factors [7].
A number of these intrinsic factors have been identified, including
Oct3/4 and Nanog [8]. Leukemia inhibitory factor (LIF) [9,10], a
known extrinsic factor, plays an important role in maintaining the
self-renewal of mouse ESCs (mESCs) via signal transduction and
activator of transcription 3 (STAT3) activation [11]. It has been
reported that mESCs differentiate into primitive endoderm upon
the blockage of LIF/STAT3 signaling, and Nanog inhibits this
differentiation process [12,13]. Another extrinsic factor, BMP4,
acts in synergy with LIF to maintain self-renewal by modulating
the Smad-mediated induction of the Id (inhibitor of differentiation)
gene [14]. Wnt/b-catenin signaling also plays a role in the
regulation of self-renewal that is independent of LIF/STAT3
signaling but involves Nanog expression [15–17]. Fgf4 is produced
PLOS ONE | www.plosone.org 1 August 2012 | Volume 7 | Issue 8 | e43440
in an autocrine fashion in mESCs, and Fgf4/extracellular signal-
regulated kinase (Erk) signaling contributes to the differentiation of
mESCs into neural and mesodermal lineages [18].
Recently, we demonstrated that HS chains, including sulfated
regions, contribute to the self-renewal and pluripotency of mESCs
through Wnt/b-catenin and BMP/Smad signaling in culture
media containing serum and LIF [16,19]. In contrast, other
groups have reported that HS chains contribute to the initiation of
differentiation via Fgf4 signaling following LIF withdrawal
[20,21]. Therefore, HS chains contribute to both the maintenance
of the undifferentiated state and induction of differentiation. It has
also been reported that the pattern of HS chain sulfation changes
during the differentiation of mESCs into mesodermal and
neuroectodermal lineages [22,23]. Specific sulfated structures in
HS chains might contribute to these differentiation processes by
regulating several signal transduction pathways, although the
significance of the changes in the sulfation pattern of HS chains
remains unclear. We suggest that alteration of HS chain sulfation
patterning regulates differentiation in mESCs by controlling
several signaling cascades.
3-O-sulfated HS structures that are recognized by the anti-HS
antibody HS4C3 [24], which include GlcA/IdoA2S-GlcNS3S6S,
are synthesized by HS 3-O-sulfotransferase (3OST), which
transfers sulfate from PAPS (adenosine 39-phosphate 59-phos-
phosulphate) to the 3-OH position of a glucosamine residue to
form 3-O-sulfated HS [25]. Six different isoforms of 3OST have
been identified so far in mouse (3OST-1, -2, -3A, -3B, -5, and -
6). 3-O-sulfated HS serves as an entry receptor for herpes simplex
virus 1 (HSV-1) and binds to glycoprotein D of HSV-1 and
antithrombin [26]. However, it remains unclear whether 3-O-
sulfated HS structures, including the HS4C3-binding epitope,
have other functional roles, for example within signal transduc-
tion.
In this study, we investigated the contribution of the HS4C3-
binding epitope to the regulation of mESC differentiation. We
found that HS4C3-binding epitope on mESCs increased after
the induction of differentiation into primitive endoderm and
primitive ectoderm. Up-regulation of the HS4C3-binding
epitope by overexpression of 3OST induced mESC differentia-
tion even in the presence of LIF and serum, and demonstrated
that this differentiation resulted from the redistribution of Fas to
lipid rafts. In contrast, knockdown of 3OST reduced the
potential for differentiation into primitive endoderm and
primitive ectoderm. The results showed that Fas signaling via
the HS4C3-binding epitope contributes to general differentiation
in mESCs.
Materials and Methods
Construction of Expression Vectors
The 3OST-2, -5, and Fas expression vectors for transfection into
mESCs were constructed using the vector pCAGIPuro (a kind gift
of Prof. Kumiko Ui-Tei). The Fas ectodomain expression vectors,
for the production of recombinant proteins, were constructed
using the vector pGEX-6P-1 (GE Healthcare). These constructs
were produced by using the GATEWAYTM cloning system
(Invitrogen) as described previously [27]. Each construct contained
the appropriate full-length coding sequence (3OST-2, amino acids
1–367; 3OST-5, amino acids 1–346; Fas, amino acids 1–328) or
the sequence for the putative extracellular domain of Fas, or
fragments of this domain (amino acids 19–168, 19–38, and 39–
168).
Cell Culture and Transfection
R1 [28] and E14TG2a [29] mESC lines were maintained on
mouse embryonic fibroblasts (MEFs) inactivated with 10 mg/ml
mitomycin C (Sigma) in ESC medium (DMEM supplemented
with 15% FBS {Hyclone}, 1% penicillin/streptomycin {Gibco},
0.1 mM 2-mercaptoethanol {Gibco}, and 0.1 mM non-essential
amino acids {Gibco}) with 1000 U/ml LIF (Chemicon). R1 and
E14TG2a lines were gifts from Dr. Seiji Hitoshi (National Institute
for Physiological Sciences, Japan) and Prof. Kumiko Ui-Tei
(Biophysics and Biochemistry, Graduate School of Science,
University of Tokyo, Japan), respectively. MEFs were prepared
from embryos at embryonic day 14.5 (E14.5; ICR). All experi-
ments were performed in the R1 line and most were repeated
using the E14TG2a line to confirm that the results were consistent.
Prior to transfection, the mESCs were harvested and 16106
cells were replated in gelatin-coated feeder-free 60-mm culture
dishes (Iwaki) in ESC medium with LIF, and incubated for 16 h.
Subsequently (day 1), the cells were transfected with 4 mg of
pCAGI containing 3OST-2, 3OST-5, Fas or no insert (control)
using Lipofectamine 2000 (Invitrogen). On day 2, the cells were
subjected to selection with 2 mg/ml puromycin (Sigma) for 24 h.
The transfection efficiency was approximately 60%, but only
transfected cells survived after puromycin selection. On day 3 (2
days after transfection), the transfected cells were harvested and
used in the various experiments as described below. To induce
primitive endoderm, mESCs were harvested at the first and
second passages and 26105 cells were replated in gelatin-coated
feeder-free 60-mm culture dishes in ESC medium without LIF. At
the third and fourth passages, the cells were harvested and 56105
cells were replated in gelatin-coated feeder-free 60-mm culture
dishes in ESC medium without LIF. To induce embryoid body
(EB) formation, the transfected cells were transferred to 60-mm
Low Cell Binding dishes (Nunc) and cultured in ESC medium
without LIF. To analyze the inhibition of Fas signaling, the cells
were cultured in medium that contained 10 mM Ac-IETD-CHO
or 20 mM Ac-DEVD-CHO (Peptide Institute Inc) dissolved in
DMSO. Ac-IETD-CHO and Ac-DEVD-CHO are inhibitors of
caspase-8 and caspase-3, respectively.
We generated siRNA expression plasmids that targeted 3OST-5
or EGFP, as a negative control, by inserting the appropriate
dsDNAs between the BamHI and HindIII sites of pSilencer 3.1-
H1 (Ambion) or pSUPER.retro.puro (OligoEngine). The siRNA
sequences used for RNA interference (RNAi) were designed as








Stable knockdown of 3OST-5 mRNA was carried out as follows.
To produce retrovirus, the pSUPER.retro.puro constructs were
transfected into ecotropic virus-packaging (PLAT-E) cells. Super-
natants that contained virus and were derived from these PLAT-E
cultures were mixed with 8 mg/ml polybrene (Sigma) and the
virus/polybrene mixtures were incubated with mESCs for 24 h.
After infection, the cells were replated with ESC medium
containing LIF and 2 mg/ml puromycin and cultured for 5–7
days. For transient knockdown of 3OST-5 mRNA by RNAi, 4 mg
of the pSilencer 3.1-H1 construct for 3OST-5 were transfected into
mESCs by the method described above.
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Figure 1. Increase in the HS4C3-binding epitope induces differentiation. (A) FACS analysis, using the HS4C3 antibody, of mESCs after LIF
withdrawal up to day 8. mESCs were cultured in the presence of LIF until day 0. In the left panel, a histogram shows a representative result of the
FACS analysis (black line, in the presence of LIF; red line, 4 days after LIF withdrawal; green line, 6 days after LIF withdrawal; blue line, 8 days after LIF
withdrawal). The gray line shows the result obtained from cells not treated with primary antibody. In the right panel, the values shown are the mean
fluorescence intensity 6 SD after normalization against mESCs cultured in the presence of LIF (arbitrary value= 1). (B) Immunostaining, using the
HS4C3 antibody, of non-permeabilized mESCs cultured in the presence of LIF (+LIF) or mESCs cultured for 7 days in the absence of LIF (2LIF) (upper
panel). Lower panel shows DIC images. Scale bar, 5 mm. Representative confocal images are shown. (C) Real time PCR analysis of mESCs after LIF
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FACS Analysis
Cells harvested 2 days after transfection were incubated with
a vesicular stomatitis virus (VSV)-tagged phage-display antibody
against specific sulfated HS structure [30], in FACS buffer
(0.5% bovine serum albumin {BSA} and 0.1% sodium azide in
PBS). After washing, the cell suspension was incubated with
mouse anti-VSV glycoprotein antibody (Sigma) in FACS buffer,
washed, and stained with a Cy5-conjugated anti-mouse IgG
antibody (Jackson ImmunoResearch) or FITC-conjugated anti-
mouse IgG antibody (Sigma) in FACS buffer. Cell analysis was
performed using a FACSAria Cell Sorter (Becton Dickinson).
We used the VSV-tagged HS4C3 antibody to analyze 3-O-
sulfated HS structures [31]. We also used the anti-HS antibody
10E4 (Seikagaku Corp.) and FITC-conjugated anti-mouse IgM
as the second antibody (Sigma) for antibody 10E4. We analyzed
the expression of Fas using the FITC-conjugated anti-Fas
antibody Jo2 (Becton Dickinson). The cells were permeabilized
in 70% ethanol for 30 min on ice before Fas staining to enable
analysis of total Fas expression [32]. The effect of the inhibition
of protein secretion on Fas expression was examined using cells
that had been treated with 5 mg/ml brefeldin A (Sigma) for 2 h
before harvest.
Measurement of Viability
Two days after transfection, cells were harvested and replated in
triplicate at 0.86104 cells per well in 96-well 0.2% gelatin-coated
plates in ESC medium with LIF. Cell Counting Kit-8 solution
(Dojindo) was added after 0, 24 or 48 h and the cells were
incubated for a further 2 h. The resulting soluble formazan
product, which reflects the number of living cells, was measured at
450 nm. Viability was indicated by the ratio of the absorbance of
the transfected cells to that of control cells.
Measurement of Apoptotic Cells
Two days after transfection, cells were harvested and suspended
in annexin V-binding buffer (BioVision). Annexin V-FITC
(BioVision) was added to the cell suspensions, which were
incubated at room temperature for 5 min in the dark. The
suspensions were analyzed using a FACSAria Cell Sorter.
Analysis of Proteins by Immunoblotting
Two days after transfection, protein samples for immunoblot-
ting were prepared as follows. To analyze phosphorylated protein
in transfected cells after extrinsic stimulation, mESC culture
medium was replaced with serum-free ESC medium without LIF
for 4 h and the cells were stimulated for 5, 10 or 20 min with FBS
or 5 min Fgf4. Cells were then lysed with lysis buffer (50 mM Tris-
HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 1 mM Na3VO4,
10 mM NaF, protease inhibitors). Lipid rafts were isolated as
described previously [33,34,35]. Harvested cells were suspended in
0.5 ml of homogenization buffer (50 mM Tris-HCl pH 6.5,
150 mM NaCl, 5 mM EDTA, 1 mM Na3VO4, 10 mM NaF,
protease inhibitors) and homogenized by passing through a 20-G
needle 50 times on ice. After adding 0.5 ml of lysis buffer (50 mM
Tris-HCl pH 6.5, 150 mM NaCl, 5 mM EDTA, 1.2% Triton X-
100, 1 mM Na3VO4, 10 mM NaF, protease inhibitors) to the
suspension, it was homogenized again by passing through a 20-G
needle 10 times and incubated for 30 min on ice. The extract
(approx. 1 mg of total protein) was mixed with 1.0 ml of 85%
sucrose (Wako) to produce a 42.5% sucrose solution, transferred to
a centrifuge tube (Beckman Coulter), and overlaid with 5 ml of
30% sucrose solution and 3 ml of 5% sucrose solution containing
50 mM Tris-HCl pH 6.5, 150 mM NaCl, and 5 mM EDTA. The
discontinuous sucrose gradients were centrifuged at 4uC for 16 h
in an SW41 Ti rotor (Beckman Coulter) at 30,000 rpm. The
gradient was divided into nine fractions from the bottom to the
top. The proteins in each fraction were precipitated with 10%
trichloroacetic acid and washed with 5% trichloroacetic acid,
followed by cold acetone. The precipitate was dried and dissolved
in lysis buffer. Aliquots of 10 mg of total protein from the cell
samples or half the total protein from each fraction were separated
by 10% or 15% SDS-PAGE and transferred onto PVDF
membranes (Millipore). After blocking, the membranes were
incubated with antibodies against cleaved (activated) caspase-3,
cleaved (activated) caspase-8, uncleaved (unactivated) caspase-8,
Bad, Erk1/2, phosphorylated Erk1/2 (Thr202 and Tyr204) (Cell
Signaling Technology); b-actin (Sigma); Akt, phosphorylated Akt
(Ser472 and Ser473), Flotillin-1 (Becton Dickinson); Fas (M-20)
(Santa Cruz); transferrin receptor (Zymed); or Nanog (Repro-
CELL). The membranes were then incubated with the appropriate
horseradish peroxidase (HRP)-conjugated secondary antibodies
(Cell Signaling Technology), washed, and developed with ECL
Plus reagents (GE Healthcare).
Binding Assay
The putative extracellular domain of mouse Fas or fragments
thereof (amino acids 19–168, 19–38, and 39–168, lacking the
signal peptide) and the domains that included point mutations
(K32A, R34A, R35A, R36A, and H38A) were expressed in
Escherichia coli BL21 cells as fusion proteins with gluthathione
sepharose transferase (GST), and purified with gluthathione
sepharose 4B resin (GE Healthcare) according to the manufac-
turer’s instructions. The K32A, R34A, R35A, R36A, and H38A
point mutants were generated from the template pGEX-6P-1-Fas
(amino acids 19–168) using the KOD Plus Mutagenesis Kit
(Toyobo) according to the manufacturer’s instructions. Fas binding
activity was examined by an overlay assay as described previously
[36]. Fas overlay assays were performed on a PVDF membrane
using the purified GST-Fas fusion protein. Samples (2.5 mg of total
protein) were separated by 8% SDS-PAGE and then transferred to
PVDF membranes. The membranes were blocked in blocking
buffer (5% non-fat dry milk in PBS pH 6.5), and then incubated
with 10 nM GST-Fas, GST-mutated Fas, or GST-Fas pre-mixed
with HS4C3 (1:1000) for 2 h at 4uC in PBS pH 6.5 with 3% BSA.
The membranes were washed in buffer (PBS pH 6.5, 0.1% Tween
withdrawal up to day 6. The values shown are means 6 SD. (D) FACS analysis, using the HS4C3 antibody, of mESCs at 2 days after transfection with
the 3OST-5 expression construct. In the left panel, a histogram shows a representative result of the FACS analysis (black line, control cells; red line, cells
overexpressing 3OST-5). The gray line shows the result obtained from cells not treated with primary antibody. The control cells were transfected with
empty pCAGI vector. In the right panel, the values shown are the mean fluorescence intensity 6 SD after normalization against control cells (arbitrary
value = 1). (E) Self-renewal assay with cells overexpressing 3OST-5. Left panels show photographs of representative colonies. A high magnification
image is shown at the bottom of each photograph to the right. Scale bars, 200 mm. Right panel shows the proportion of AP-positive colonies. The
values shown are the mean 6 SD. Two days after transfection, mESCs were replated in ESC medium with or without LIF. (F) and (G) Real time PCR
analysis of markers of the undifferentiated (F) and differentiated state (G) in mESCs at 4 days after transfection with the 3OST-5 expression construct.
The values shown are means 6 SD after normalization against control cells (arbitrary value = 1). DIC, Differential interference contrast. *, P,0.01; **,
P,0.05. At least three independent experiments were performed in each case.
doi:10.1371/journal.pone.0043440.g001
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Figure 2. Activation of caspase-3 and degradation of Nanog are induced in cells overexpressing 3OST-5. (A) Viability of cells
overexpressing 3OST-5. Viability was measured as described in Materials and Methods. The values shown are the means 6 SD of triplicate
measurements from one representative experiment after normalization against control cells (arbitrary value = 1). (B) Measurement of the rate of
apoptosis in mESCs using an annexin V-FITC kit at 2 days after transfection with the 3OST-5 expression construct. The values shown are the means 6
SD after normalization against control cells (arbitrary value= 1). (C) FACS analysis, using the HS4C3 antibody and annexin V, of mESCs at 2 days after
transfection with the 3OST-5 expression construct (left graph) or of mESCs cultured for 8 days in the absence of LIF (2LIF) (right graph). The
HS4C3-Binding Epitope Contributes to Fas Signaling
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20) and incubated with HRP-conjugated anti-GST antibody
(Santa Cruz) for 1 h at room temperature. Blots were developed
with ECL Plus reagents.
RT-PCR and Real Time PCR
Total RNA was isolated from cells using TRIzolH Reagent
(Invitrogen) and reverse transcribed using an oligo-dT primer
(Invitrogen) and a Superscript II First Strand Synthesis Kit
(Invitrogen). Real time PCR was performed using an ABI
PRISMH 7700 Sequence Detection System (Applied Biosystems).
The relative amounts of each mRNA were normalized against the
amount of b-actin or GAPDH mRNA in the same sample. Primer
sets and probes for real time PCR are listed in Tables S1 and S2,
respectively.
Self-Renewal Assay
Two days after transfection of pCAGI that contained 3OST-5
or Fas, mESCs were replated at 16104 cells per gelatin-coated
60-mm tissue culture dish in ESC medium with or without LIF.
In the case of treatment with the inhibitors IETD and DEVD,
the mESCs were treated throughout the period from transfection
to alkaline phosphatase (AP) staining. To detect undifferentiated
cells, cells were fixed and stained with 5-bromo-4-chloro-3-
indolyl phosphate-nitroblue tetrazolium (Nacalai Tesque) 5 days
after replating. AP-positive colonies were counted by microscopy.
Immunostaining of mESCs after Induction of
Differentiation into Primitive Endoderm
mESCs were fixed with 4% paraformaldehyde and washed with
PBS. Subsequently, the cells were blocked with buffer1 (5% BSA,
1% normal goat serum in PBS). After washing with buffer1, the
cells were incubated with HS4C3 antibody in buffer1. Then, the
cells were washed again and incubated with mouse anti-VSV
glycoprotein antibody (Sigma). Finally, the cells were washed and
costained with Cy5-conjugated anti-mouse IgG (Jackson Immu-
noResearch) and the FITC-conjugated anti-Fas antibody Jo2 in
buffer1. To permeabilize the cells, 0.05% Triton X-100 was added
to buffer1 throughout the process. Immunofluorescence images
were taken using an LSM 5 Pascal confocal laser scanning
microscope (Carl Zeiss) with a 63 6/1.3 objective at room
temperature.
Results
Increase in HS4C3-Binding Epitope Induces
Differentiation
First, we examined changes in HS chain sulfation on the surface
of mESCs after induction of differentiation into primitive
endoderm by LIF withdrawal. The differentiated cells displayed
a reduction in the expression of Nanog and an increase in the
expression of Gata6, which is a marker of the primitive endoderm
(data not shown). Fluorescence-activated cell sorting (FACS) using
the anti-3-O-sulfated HS antibody HS4C3 showed that the
HS4C3-binding epitope increased steadily in differentiated
mESCs (Figure 1A). Indeed, immunostaining of non-permeabi-
lized cells showed that the HS4C3-binding epitope increased on
the surface of differentiated mESCs in the absence of LIF for 7
days (Figure 1B). The expression of 3OST-5, which has been
reported to synthesize the HS4C3-binding epitope, increased
when mESCs were induced to form primitive endoderm by the
withdrawal of LIF (Figure 1C). Next, we performed FACS analysis
of cells transfected with an expression construct for 3OST-5 using
the antibody HS4C3. The HS4C3-binding epitope was increased
in cells overexpressing 3OST-5, but the amount of HS did not
differ between the cells overexpressing 3OST-5 and the control
cells (Figure 1D and Figure S1).
To determine whether overexpression of the HS4C3-binding
epitope induced differentiation of mESCs, we performed a self-
renewal assay with cells overexpressing 3OST-5. The number of
AP-positive colonies that were derived from cells overexpressing
3OST-5 decreased to approximately 30% of the number obtained
with control cells even in the presence of LIF and serum in
clonal density culture, which demonstrated a reduction of self-
renewal in cells overexpressing 3OST-5 (Figure 1E). Then, we
examined the expression of Oct3/4 and Nanog in cells overex-
pressing 3OST-5 that were cultured with LIF; Oct3/4 and Nanog
are markers of the undifferentiated state. Expression of both
Oct3/4 and Nanog was significantly lower in cells overexpressing
3OST-5 than in control cells that were cultured with LIF
(Figure 1F). Thus, overexpression of the HS4C3-binding epitope
induced differentiation of mESCs. To characterize the differen-
tiating mESCs, we evaluated the expression of several germ layer
markers. In cells overexpressing 3OST-5, we detected higher
expression of markers of the primitive endoderm (Gata6) and
primitive ectoderm (Fgf5) than in control cells (Figure 1G). Other
lineage markers (neuroectoderm, Isl1; mesoderm, Brachyury;
primitive endoderm, Gata4; parietal endoderm, LamininB1;
visceral endoderm, Bmp2; trophoblast, Cdx2) were either
expressed at a lower level or were unaltered as compared with
control cells that were cultured with LIF (Figure 1G). These
results demonstrate that the increase in the HS4C3-binding
epitope induced differentiation into primitive endoderm and
primitive ectoderm during culture in the presence of LIF, which
should maintain the undifferentiated state.
Activation of Caspase-3 and Degradation of Nanog are
Induced in Cells Overexpressing 3OST-5
Next, we examined cell viability because the cell number for
cells overexpressing 3OST-5 was low compared with that for
control cells. Indeed, cells overexpressing 3OST-5 displayed
decreased viability, which might be caused by apoptosis
(Figure 2A). Cell differentiation and apoptosis are linked, and
mESCs undergo caspase-mediated apoptosis during differentiation
induced by LIF withdrawal [37]. As shown in Figure 2B, the
proportion of annexin V-positive cells increased significantly in
cells overexpressing 3OST-5 as compared with control cells. In
addition, the ratio of annexin V and HS4C3 double-positive cells
was approximately five times higher in cells overexpressing 3OST-
5 and mESCs induced to differentiate by culture in the absence of
LIF for 8 days than in control cells (Figure 2C). These results
histograms show the ratio of the HS4C3 and annexin V double positive cells to control cells (left graph) or mESCs cultured in the presence of LIF (+LIF)
(right graph) (value = 1). Values are the means6 SD. (D) and (E) Western blot analysis, using antibodies against cleaved caspase-3 or Nanog, of mESCs
at 2 days after transfection with the 3OST-5 expression construct (D, left two lanes and E) or of mESCs cultured for 8 days in the absence of LIF (2LIF)
(D, right two lanes). The histograms show mean densitometric readings 6 SD after normalization against control cells (D, left two lanes and E), or
mESCs cultured in the presence of LIF (+LIF) (D, right two lanes) (arbitrary value= 1). (F) Real time PCR analysis of Nanog in mESCs at 2 days after
transfection with the 3OST-5 expression construct. The values shown are means 6 SD after normalization against control cells (arbitrary value = 1). *,
P,0.01; **, P,0.05. Three independent experiments were performed in each case.
doi:10.1371/journal.pone.0043440.g002
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Figure 3. The expression of Fas increased on the surface of cells overexpressing 3OST-5. (A) FACS analysis of cell surface Fas (left panel) or
total Fas (right panel) in cells overexpressing 3OST-5 using an anti-Fas antibody (black line, control cells; red line, cells overexpressing 3OST-5). The gray
line shows the result obtained from cells not treated with primary antibody. As described in Materials and Methods, mESCs were permeabilized to
observe total Fas expression or not permeabilized to observe Fas expression on the cell surface. (B) FACS analysis, using an anti-Fas antibody, of Fas
on the surface of cells that were overexpressing 3OST-5 and had been treated with brefeldin A. The histograms show the ratio of the mean
fluorescence intensity of the treated cells to that of non-treated control cells (arbitrary value= 1). Values are the means 6 SD. (C) FACS analysis of cell
surface Fas in mESCs cultured for 8 days in the absence of LIF using an anti-Fas antibody. In the left panel, a histogram shows a representative result
of the FACS analysis (black line, in the presence of LIF; red line, in the absence of LIF). The gray line shows the result obtained from cells not treated
HS4C3-Binding Epitope Contributes to Fas Signaling
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indicate that overexpression of the HS4C3-binding epitope
induced both differentiation and apoptosis of mESCs in a similar
manner to LIF withdrawal.
Caspase-3 is activated during mESC differentiation (Figure 2D,
[37]). Therefore, we investigated whether caspase-3 is activated in
cells overexpressing 3OST-5 and found that its level of activation
was indeed higher in these cells than in control cells (Figure 2D).
Given that activated caspase-3 degrades Nanog, which results in
mESC differentiation [38], we compared the amounts of Nanog in
cells overexpressing 3OST-5 and control cells. The amount of
Nanog protein was decreased in cells overexpressing 3OST-5
(Figure 2E), whereas the level of Nanog mRNA was not decreased
(Figure 2F). These results suggest that induction of differentiation
in cells overexpressing 3OST-5 depends on the activation of
caspase-3 followed by the degradation of Nanog.
The Expression of Fas Increased on the Surface of Cells
Overexpressing 3OST-5
To clarify the mechanism by which caspase is activated during
mESC differentiation, we investigated the contribution of
upstream components of the caspase cascade. Fas (CD95 or
Apo-1) is a type I membrane protein and a member of the tumor
necrosis factor receptor family. Fas signaling, which is activated by
interaction between Fas and the Fas ligand (FasL) or simply by the
redistribution of Fas into lipid rafts, comprises part of the caspase
activation cascade [39,40]. First, we determined the distribution of
Fas on cells overexpressing 3OST-5. Fas was present at a very low
level on the surface of control cells but this level was clearly higher
on cells overexpressing 3OST-5 (Figure 3A left histogram and 3B).
However, the total level of Fas did not change between the two cell
types (Figure 3A right histogram). The increase in the level of Fas
on the surface of cells overexpressing 3OST-5 was inhibited by
treating the cells with brefeldin A, which inhibits the transport of
proteins from the ER to the Golgi and leads to the accumulation of
proteins inside the ER (Figure 3B). Furthermore, the level of Fas
on the surface of mESCs differentiated by culture in the absence of
LIF for 8 days was increased (Figure 3C).
Overexpression of the HS4C3-Binding Epitope Recruits
Fas into Lipid Rafts, which Activates Fas Signaling
Next, we analyzed biochemically whether Fas was localized in
lipid rafts in differentiated cells. The separation of lipid rafts and
non-rafts was confirmed by western blotting using Flotillin-1 as a
marker of the raft fraction (fractions 3–5) and the transferrin
receptor as a marker of the non-raft fraction (fractions 7–9)
(Figure 4A). Fas was located in the raft fraction in cells
overexpressing 3OST-5 in the presence of LIF (+LIF) and in
mESCs differentiated by culture in the absence of LIF for 6 days
(2LIF) (Figure 4A), which indicated that the activation of Fas
signaling in these cells was mediated by the redistribution of Fas
into lipid rafts. In addition, the HS4C3-binding epitope was
localized in lipid rafts in cells overexpressing 3OST-5 (Figure S2).
Caspase-8 is a downstream component of the Fas signaling
pathway. We also found that the level of activated caspase-8 was
increased, and the level of unactivated caspase-8 decreased, in cells
overexpressing 3OST-5 and in mESCs after the induction of
differentiation by LIF withdrawal for 8 days (Figure 4B). These
data indicated that Fas signaling had been activated.
To determine whether Fas signaling induced the differentiation
of mESCs, we performed a self-renewal assay with cells
overexpressing Fas. FACS analysis showed that the amount of
Fas on the cell surface was increased in cells overexpressing Fas
(Figure 4C). The number of AP-positive colonies that were derived
from cells overexpressing Fas was reduced significantly to the same
number as those derived from cells overexpressing 3OST-5, even
in the presence of LIF and serum in clonal density culture
(Figure 4D). This indicated that up-regulation of Fas reduced the
self-renewal of mESCs.
We examined the putative interaction of Fas and the HS4C3-
binding epitope by using an overlay assay. Given that we expected
the heparin-binding domain (KLRRRVH) in the Fas ectodomain
to bind in the Golgi to sulfated regions of HS chains, including the
HS4C3-binding epitope, we used several types of the recombinant
Fas ectodomain for the assay (Figure 4E). As shown in Figure 4F
(F-2), overlaid Fas (indicated by ** in the figure) increased in
parallel with the HS4C3-binding epitope (indicated by * in
Figure 4F (F-1)) in cells overexpressing 3OST-5, which indicated
that the Fas ectodomain bound specifically to the HS4C3-binding
epitope. Addition of HS4C3 blocked Fas binding completely,
which confirmed the interaction was specific (Figure 4F (F-3)).
Furthermore, point mutations in the heparin-binding domain
(ALAAAVA) of Fas abolished the binding (Figure 4F (F-4)). In
addition, we prepared two separate fragments of the Fas
ectodomain, amino acids 19–38 and 39–168, (Figure 4E) and
performed the overlay assay with these fragments. Binding of the
fragment that comprised amino acids 19-38, which included the
heparin-binding domain, was increased in cells overexpressing
3OST-5 (Figure 4G (G-2)). In addition, the fragment that
comprised amino acids 39-168 did not bind to samples from
control cells and cells overexpressing 3OST-5 (Figure 4G (G-4)).
Addition of HS4C3 also blocked fragments binding (Figure 4G (G-
3, G-5)). Therefore, we concluded that amino acids 19–38 of Fas,
which include the heparin-binding domain, are necessary for
interaction with the HS4C3-binding epitope. These findings
demonstrated for the first time that Fas binds to HS chains,
including the HS4C3-binding epitope, through the region that
contains the heparin-binding domain (KLRRRVH).
Another important caspase cascade is mediated by changes in
mitochondrial permeability, which are regulated by proapoptotic
Bcl-2 proteins such as Bad. Bad is phosphorylated as a result of the
activation of signal transduction by several survival factors,
including growth factors. We examined the phosphorylation of
Akt, which is upstream of Bad, after serum stimulation and
observed a similar increase in the level of phosphorylated Akt in
control cells and cells overexpressing 3OST-5 (Figure S3A).
Interestingly, the expression of Bad was markedly decreased in
cells overexpressing 3OST-5, which indicated a reduction in the
Bad-mediated proapoptotic state (Figure S3B). These results
demonstrate that activation of caspase-3 in cells overexpressing
3OST-5 was not due to a defect in the mitochondrial pathway.
Taken together, our findings provide the first demonstration
that redistribution of Fas from intracellular pools to lipid rafts on
the cell surface depends on an interaction between Fas and the
HS4C3-binding epitope, and is followed by the activation of Fas
signaling and caspase-3.
with primary antibody. In the right panel, the values shown are the mean fluorescence intensity 6 SD after normalization against mESCs cultured in
the presence of LIF (arbitrary value= 1). *, P,0.01; **, P,0.05. Three independent experiments were performed in each case.
doi:10.1371/journal.pone.0043440.g003
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Differentiation of mESCs Induced by Overexpression of
the HS4C3-Binding Epitope is Inhibited by Blockage of
Fas Signaling
To confirm that activation of Fas signaling via overexpression of
the HS4C3-binding epitope was involved in mESC differentiation,
we investigated whether the reduced self-renewal capability of cells
overexpressing 3OST-5 could be rescued by blocking Fas signaling
using the peptides Ac-IETD-CHO (IETD) and Ac-DEVD-CHO
(DEVD), which block the activity of caspase-8 and caspase-3,
respectively. We found that treatment of cells overexpressing
3OST-5 with the inhibitors inhibited caspase-3 activation and
rescued the degradation of Nanog protein (Figure 5A and 5B).
Next, we compared the morphologies of control cells and cells
overexpressing 3OST-5. Control cells had an undifferentiated
appearance with a moderately packed morphology (Figure 5C). In
contrast, almost all cells overexpressing 3OST-5 had a flattened,
differentiated morphology (Figure 5C). Some IETD-treated cells
had a similar morphology to undifferentiated mESCs (Figure 5C).
Then, we performed a self-renewal assay and counted the AP-
positive colonies. Treatment of cells overexpressing 3OST-5 with
DEVD or IETD restored the proportion of AP-positive colonies to
a level similar to that obtained with control cells (Figure 5D).
Furthermore, the level of Oct3/4 and Nanog mRNA in cells
overexpressing 3OST-5 was higher after IETD treatment than in
untreated cells (Figure 5E). Thus, we demonstrated that activation
of Fas signaling via overexpression of the HS4C3-binding epitope
induced differentiation in mESCs. As shown in Figure 4B, Fas
signaling was activated in mESCs after the induction of
differentiation by LIF withdrawal. We expected that blocking
Fas signaling would inhibit the induction of differentiation by LIF
withdrawal. Indeed, resistance to differentiation caused by
activation of Fas signaling was observed in mESCs treated with
IETD in the absence of LIF (Figure 5F). These results indicated
Figure 4. Fas signaling is activated by redistribution of Fas into
lipid rafts in cells overexpressing 3OST-5. (A) Western blot analysis
of raft and non-raft fractions, using anti-Flotillin-1 (raft), anti-transferrin
receptor (non-raft), and anti-Fas antibodies, of mESCs at 2 days after
transfection with the 3OST-5 expression construct (upper two panels) or
mESCs at 6 days after LIF withdrawal (lower two panels). At least two
independent experiments were performed. Representative results are
shown. (B) Western blot analysis, using antibodies against uncleaved
and cleaved caspase-8, of mESCs at 2 days after transfection with the
3OST-5 expression construct (left and middle right panels) or mESCs at 8
days after LIF withdrawal (middle left and right panels). The histograms
show mean densitometric readings 6 SD after normalization against
control cells (left and middle right panels) or mESCs cultured in the
presence of LIF (middle left and right panels) (arbitrary value= 1). Three
independent experiments were performed. *, P,0.01; **, P,0.05. (C)
FACS analysis, using the anti-Fas antibody, of mESCs at 2 days after
transfection with the Fas expression construct. In the left panel, a
histogram shows a representative result of the FACS analysis (black line,
control cells; red line, cells overexpressing Fas). The gray line shows the
result obtained for cells that were not treated with the primary
antibody. In the right panel, the values shown are means 6 SD after
normalization against control cells (arbitrary value= 1). Three indepen-
dent experiments were performed. *, P,0.01. (D) Self-renewal assay in
cells overexpressing Fas. The proportion of AP-positive colonies is
shown. The values shown are the mean 6 SD. Two days after
transfection, mESCs were replated in ESC medium with or without LIF. *,
P,0.01. (E) Mutations and truncations of the recombinant Fas
ectodomain. (F) and (G) Overlay assay using the GST-fused recombinant
Fas ectodomain. F-1 and G-1 show a western blot using the HS4C3
antibody. The single asterisk (*) shows the effect of the increase in the
HS4C3-binding epitope on several core proteins in cells overexpressing
3OST-5. F-2 and G-2,-4 show the overlay assay using the Fas ectodomain
(F-2, aa 19–168) or fragments of the Fas ectodomain (G-2, aa 19–38; G-4,
aa 39–168). F-3 and G-3,-5 show the overlay assay using the Fas
ectodomain (F-3, aa 19–168) or fragments of the Fas ectodomain (G-3,
aa 19–38; G-5, aa 39–168) pre-mixed with HS4C3 antibody. F-4 shows
the overlay assay using the mutated Fas ectodomain (aa 19–168). The
double asterisk (**) shows increased binding of the Fas ectodomain in
cells overexpressing 3OST-5. b-actin was used as a loading control for
each sample (F-5 and G-6). mESCs at 2 days after transfection with the
3OST-5 expression construct were used for each analysis. Two
independent experiments were performed. Representative results are
shown. GST, glutathione S-transferase.
doi:10.1371/journal.pone.0043440.g004
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that Fas signaling induces the differentiation caused by LIF
withdrawal in mESCs. Taken together, rescue experiments that
involved blocking Fas signaling demonstrated that the degradation
of Nanog protein and induction of differentiation were actually
caused by Fas signaling via HS4C3-binding epitope.
Decrease in the HS4C3-Binding Epitope Inhibits
Differentiation and Apoptosis
To examine and confirm the requirement for HS4C3-binding
epitope for the differentiation of mESCs, we performed stable and
transient knockdown (KD) of 3OST-5 mRNA using RNAi. We
designed two constructs that targeted 3OST-5 (3OST-5-1 and
3OST-5-2, which expressed different siRNAs targeting 3OST-5)
and one that targeted EGFP as a negative control. The level of
3OST-5 expression was reduced in both stable and transient 3OST-
5 KD cells (Figure 6A and 6J). FACS analysis showed that the
HS4C3-binding epitope was decreased in both stable and transient
3OST-5 KD cells (Figure 6B and K). Then, we performed a self-
renewal assay with the stable 3OST-5 KD cells. The number of
AP-positive colonies did not differ between the stable 3OST-5 KD
cells and the control cells in the presence of LIF and serum in
clonal density culture (Figure 6C). Furthermore, the expression of
markers of the undifferentiated and differentiated states did not
change even in the stable 3OST-5 KD cells (Figure S4). These
results demonstrated that the reduction in the HS4C3-binding
epitope did not affect the self-renewal capability of mESCs.
To determine whether down-regulation of the HS4C3-binding
epitope affected the potential of mESCs for differentiation, stable
3OST-5 KD cells were induced to form primitive endoderm by
LIF withdrawal for 6 days. In the stable 3OST-5 KD cells, the
increase in the expression of Gata6 (primitive endoderm marker)
that was seen in the control cells was inhibited (Figure 6D). This
finding indicated that the HS4C3-binding epitope was necessary
for differentiation into primitive endoderm. Next, we investigated
in vitro differentiation into embryoid bodies (EBs), which comprise
three germ layers: endoderm, mesoderm, and ectoderm. Expres-
sion of the HS4C3-binding epitope was increased during EB
formation in control cells (Figure 6B). In EBs derived from stable
3OST-5 KD cells, HS4C3-binding epitope was decreased com-
pared with that in control EBs (Figure 6B). In turn, the expression
of Fgf5 (primitive ectoderm marker), Goosecoid (mesoderm marker),
Sox17 (endoderm marker), and Pax6 (ectoderm marker) was
decreased by down-regulation of the HS4C3-binding epitope
(Figure 6E). Furthermore, Nanog and Oct3/4 were expressed at a
higher level in stable 3OST-5 KD cells than in control cells at 4
days after EB formation (Figure 6E). These data demonstrated that
differentiation into all three germ layers was inhibited by down-
regulation of the HS4C3-binding epitope during EB formation.
Then, we examined Fgf4/Erk signaling, which is reported to be a
trigger of stem cell differentiation [18], and observed no
differences in the level of phosphorylated Erk1/2 between stable
3OST-5 KD cells and control cells after exposure to Fgf4
(Figure 6F). Hence, Fgf4/Erk signaling did not contribute to the
reduction of the potential for differentiation in stable 3OST-5 KD
cells. Given the result obtained in the present study that the
HS4C3-binding epitope contributed to Fas signaling during the
differentiation of mESCs into primitive endoderm, we expected
that Fas signaling would also function during EB formation.
Therefore, we used IETD, a caspase-8 inhibitor, to analyze the
role of Fas signaling in EB differentiation. Treatment with IETD
throughout EB differentiation led to a reduction in the expression
of Fgf5 (primitive ectoderm marker) and Goosecoid (mesoderm
marker), which indicated that Fas signaling was necessary for EB
differentiation (Figure 6G). The findings demonstrated that Fas
signaling via the HS4C3-binding epitope induced normal EB
differentiation. In addition, in EBs derived from cells overexpress-
ing 3OST-5, expression of the HS4C3-binding epitope, Fgf5, and
Goosecoid were increased as compared with EBs derived from
control cells (Figure 6H and 6I). Furthermore, as shown in
Figure 6L, the population of annexin V-positive cells was increased
in control cells after LIF withdrawal for 24 hours, whereas that of
annexin V-positive cells did not increase in response to LIF
withdrawal in 3OST-5 transient KD cells. These data showed that
Fas signaling via the HS4C3-binding epitope was indispensable for
the induction of apoptosis and differentiation of mESCs into
primitive endoderm and EBs.
Fas Colocalizes with HS4C3-Binding Epitope in mESCs
We examined the localization of HS4C3-binding epitope and
Fas in mESCs during differentiation in response to LIF
withdrawal. In the undifferentiated state in the presence of LIF,
confocal slices showed that the HS4C3-binding epitope was
colocalized with Fas in the intracellular Golgi compartment
around the nucleus, not on the cell surface (Figure 7A, indicated
by the arrowheads in the upper panels). However, in mESCs
induced to differentiate by culture in the absence of LIF for 5 or 7
days, expression of the HS4C3-binding epitope increased, and
colocalization of the HS4C3-binding epitope and Fas was
observed as dots on the cell surface (Figure 7A, indicated by the
arrowheads in the middle and lower panels). These images were
consistent with the increase in HS4C3-binding epitope and Fas on
the surface of differentiated cells that was shown by the FACS
analysis in Figure 3A, and supported the redistribution of Fas into
lipid rafts that was indicated by the biochemical analysis in
Figure 4A. Taken together, the results demonstrated that Fas,
which was localized to the Golgi in the undifferentiated state, was
shifted to lipid rafts on the cell surface by binding to the HS4C3-
binding epitope during differentiation.
Figure 5. Differentiation induced by overexpression of the HS4C3-binding epitope is inhibited by an inhibitor of Fas signaling. (A)
and (B) Western blot analysis using antibodies against cleaved caspase-3 and Nanog in the presence or absence of IETD or DEVD, peptides that block
caspase-8 and caspase-3, respectively. Representative results are shown. The histograms show mean densitometric readings6 SD after normalization
against cells overexpressing 3OST-5 but not treated with IETD or DEVD (arbitrary value= 1). mESCs were analyzed at 2 days after transfection with the
3OST-5 expression construct. (C) Representative photomicrographs of transfected cells in the presence or absence of IETD. Scale bars, 200 mm. A triple
asterisk (***) indicates a high magnification image of the boxed area (Scale bars, 100 mm). mESCs were analyzed at 4 days after transfection with the
3OST-5 expression construct. (D) Self-renewal assay with cells overexpressing 3OST-5 treated with IETD or DEVD. Left panels show photographs of
representative colonies. Scale bars, 200 mm. The right panel shows the proportion of AP-positive colonies. The values shown are the mean6 SD. Two
days after transfection, mESCs were replated in ESC medium with LIF. mESCs were cultured with inhibitors throughout the period from transfection
to AP staining. (E) Real time PCR analysis of markers of the undifferentiated state. The values shown are means 6 SD after normalization against cells
overexpressing 3OST-5 but not treated with IETD (arbitrary value = 1). mESCs were analyzed at 4 days after transfection with the 3OST-5 expression
construct. (F) Self-renewal assay after treatment with IETD in the presence or absence of LIF. The ratio of AP-positive colonies is shown. The values
shown are the mean 6 S.D. IETD, Ac-IETD-CHO; DEVD, Ac-DEVD-CHO; AP, alkaline phosphatase. *, P,0.01; **, P,0.05. Three independent
experiments were performed in each case.
doi:10.1371/journal.pone.0043440.g005
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Discussion
Herein we report for the first time that activation of Fas
signaling via the HS4C3-binding epitope induced the differenti-
ation into primitive endoderm and primitive ectoderm from
mESCs. From our results, we propose the following scheme
(Figure 7B). The level of the HS4C3-binding epitope in mESCs
increased during differentiation (Figure 1A, 1B, and Figure 6B).
The HS4C3-binding epitope interacted with the heparin-binding
domain (KLRRRVH) of Fas in the Golgi, which resulted in the
redistribution of Fas to lipid rafts and the activation of Fas
signaling. Activation of Fas caused degradation of Nanog via
activated caspase-3, which induced differentiation (Figure 2D and
2E). The proposed scheme was supported by rescue experiments
in which Fas signaling was blocked (Figure 5) and by confocal
slices (Figure 7A). Therefore, we propose that the activation of Fas
signaling mediated by the HS4C3-binding epitope is a novel
mechanism for the regulation of differentiation in mESCs.
It has been reported that Fas is transported from intracellular
pools to the cell surface in response to various stimuli [32,41].
However, the identities of the molecules that contribute to this
transport of Fas have yet to be determined. Two possible transport
pathways have been implicated. 1) The intracellular domain of
secreted proteins might interact with Fas in the cytoskeletal
network and recruit Fas from the cytoskeletal network to the cell
surface. Ivanov et al. reported that Fas-associated phosphatase-1
(FAP-1) contributes to the localization of Fas by binding via the
intracellular domain of Fas within the cytoskeletal network [41]. 2)
The extracellular domain of secreted proteins might interact with
Fas in the Golgi lumen and recruit Fas from the Golgi to the cell
surface. Our proposed scheme corresponds to this second possible
pathway. As shown in Figure 3B, the effect of brefeldin A on the
translocation of Fas was probably due to the inhibition of secretion
of HS proteoglycans (HSPGs) that contained the HS4C3-binding
epitope. Recently, it has been demonstrated that Fas is redistrib-
uted from intracellular pools to lipid rafts on the cell surface in
Swiss 3T3 cells overexpressing syndecan-2 [42]. However, the
mechanism of this redistribution has not yet been clarified. We
obtained data that demonstrated that syndecan-2 was localized to
lipid rafts in mESCs (data not shown). Considering our results and
the above reported findings, we propose that HS chains on
syndecan-2 interact with Fas in the Golgi lumen and mediate the
transport of Fas from the Golgi to the cell surface, that is, via
pathway 2) described above.
Figure 6. Decrease in the HS4C3-binding epitope inhibits
differentiation and apoptosis. (A) and (J) Real time PCR analysis of
3OST-5 in stable (A) and transient (J) 3OST-5 KD cells. The values shown
are means 6 SD after normalization against control cells (arbitrary
value = 1). (B) FACS analysis using the anti-HS antibody HS4C3 (black
line, control ESCs; blue line, stable 3OST-5-1 KD ESCs; red line, control
EBs; green line, stable 3OST-5-1 KD EBs). The control cells were
transfected with the construct that targeted EGFP. The gray line shows
the result obtained for cells not treated with primary antibody. (C) Self-
renewal assay with stable 3OST-5 KD cells. Left panels show
photographs of representative colonies. Scale bars, 200 mm. The right
panel shows the proportion of AP-positive colonies. The values shown
are the mean 6 SD. (D) and (E) Real time PCR analysis of marker genes
in stable 3OST-5 KD cells at 6 days after LIF withdrawal (D) and at 3
(Fgf5, Goosecoid, and Sox17), 4 (Nanog and Oct3/4), or 12 (Pax6) days
after EB formation (E). The values shown are means 6 SD after
normalization against control cells (arbitrary value= 1). (F) Western blot
analysis, using anti-pErk1/2 and Erk1/2 antibodies, of cells stimulated
with Fgf4. The histograms show mean densitometric readings 6 SD
expressed as the ratio p-Erk1/2/Erk1/2. Representative results are
shown. (G) Real time PCR analysis of marker genes, Fgf5 and Goosecoid,
in cells treated with IETD at 3 days after EB formation. The values shown
are means 6 SD after normalization against nontreated cells (arbitrary
value= 1). (H) FACS analysis using the anti-HS antibody HS4C3 in cells
overexpressing 3OST-5 at 2 days after EB formation. The values shown
are mean fluorescence intensity 6 SD. (I) Real time PCR analysis of Fgf5
and Goosecoid in cells overexpressing 3OST-5 at 0–4 days after EB
formation (black line, control cells; red line, cells overexpressing 3OST-5).
The values shown are means 6 SD from duplicate measurements from
one representative experiment. (K) FACS analysis using the anti-HS
antibody HS4C3 (black line, control cells; red line, transient 3OST-5-2 KD
cells). The gray line shows the result obtained for cells not treated with
primary antibody. (L) Measurement of apoptosis in transient 3OST-5 KD
cells using an annexin V-FITC kit at 2 days after transfection. The values
shown are the means 6 SD after normalization against control cells in
the absence of LIF (arbitrary value = 1). KD, knockdown; RNAi, RNA
interference; EB, embryoid body. *, P,0.01; **, P,0.05. Three
independent experiments were performed in each case.
doi:10.1371/journal.pone.0043440.g006
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Gabriella et al. have reported that FasL is not expressed in
undifferentiated mESCs [43]. Our preliminary studies showed that
expression of FasL was not increased in mESCs during differen-
tiation induced by LIF withdrawal or in cells overexpressing
3OST-5 (Figure S5). In tumor cells, Fas signaling is amplified by
the redistribution of Fas into lipid rafts alone, even if FasL does not
bind to Fas [39]. Therefore, the data suggest that, in cells
overexpressing 3OST-5, Fas signaling can be activated indepen-
dently of Fas/FasL interaction simply by redistributing Fas into
lipid rafts.
The in vitro activities of mouse 3OSTs have not been reported
yet. However, it has been reported that the human 3OST-2, 3, 4,
and 5 isoforms synthesize the HS4C3-binding epitope [25].
Furthermore, among human 3OST-2, 3, 4, and 5, 3OST-2 and -5
correspond clearly to mouse 3OST-2 and 3OST-5, respectively.
We performed FACS analysis using the HS4C3 antibody and
confirmed that the HS4C3-binding epitope increased in cells
overexpressing 3OST-2 or -5 (Figure S6A). In 3OST-2-transfected
cells, we obtained the same results as in 3OST-5-transfected cells
(Figure S6A–C). These data indicated that 3OST-2 also activated
Fas signaling and induced the differentiation.
As shown in Figure 1G, cells overexpressing 3OST-5 had the
potential to differentiate not only into primitive endoderm but also
into primitive ectoderm. On the other hand, stable 3OST-5 KD
cells lost the potential to differentiate into primitive endoderm and
primitive ectoderm (Figure 6A–E). Furthermore, treatment with
IETD, an inhibitor of caspase-8, interfered with normal differen-
tiation into primitive endoderm and primitive ectoderm (Figure 5F
and 6G). Therefore, the activation of Fas signaling via the HS4C3-
binding epitope, which was indicated in this study, is involved in
the differentiation of mESCs into both primitive endoderm by LIF
withdrawal and primitive ectoderm by EB formation. We showed
clearly that Fas signaling functioned during these differentiation
processes. Interestingly, although Fgf4/Erk signaling was func-
tioning, differentiation into primitive endoderm, primitive ecto-
derm, and subsequently all three germ layers was inhibited in the
stable 3OST-5 KD cells. Therefore, a signal other than Fgf4/Erk
signaling must function to induce differentiation. Hence, in
addition to Fgf4/Erk signaling, we propose that the activation of
Fas signaling via the HS4C3-binding epitope plays an important
role in the early stages of all types of differentiation in mESCs.
Supporting Information
Figure S1 The expression of HS in cells overexpressing
3OST-5. FACS analysis using the anti-HS antibody 10E4 (black line,
control cells; red line, cells overexpressing 3OST-5). The gray line shows
the result obtained for cells not treated with primary antibody.
(TIF)
Figure S2 HS4C3-binding epitope localized in lipid rafts in
cells overexpressing 3OST-5. Western blot analysis of raft and
non-raft fractions using anti-Flotillin-1 (raft), anti-transferrin receptor
(non-raft), and HS4C3 antibodies. Representative results are shown.
(TIF)
Figure S3 Mitochondrial pathways mediated by surviv-
al factors are not affected in cells overexpressing 3OST-
5. (A) and (B) Western blot analysis, using antibodies against p-
Akt, Akt, and Bad, of cells stimulated with FBS. The histograms
show mean densitometric readings 6 SD for the ratio p-Akt/Akt
or Bad/b-actin. Three independent experiments were performed,
and representative results are shown.
(TIF)
Figure S4 Pluripotency was maintained in stable 3OST-
5 knockdown cells. Real time PCR analysis of markers of the
undifferentiated and differentiated states in stable 3OST-5
knockdown cells. The values shown are means 6 SD after
normalization against control cells (arbitrary value = 1). Three
independent experiments were performed. *, P,0.01.
(TIF)
Figure S5 The expression of Fas ligand was not
increased in cells overexpressing 3OST-5. RT-PCR
analysis of the expression of Fas ligand in cells overexpressing
3OST-5. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
(TIF)
Figure S6 The overexpression of 3OST-2 also activated
Fas signaling and induced the differentiation of mESCs.
(A) FACS analysis, using the HS4C3 antibody, of mESCs at 2 days
after transfection with the 3OST-2 expression construct (black line,
control cells; green line, cells overexpressing 3OST-2). The gray line
shows the result obtained from cells not treated with primary
antibody. (B) Real time PCR analysis of markers of the
undifferentiated state in cells overexpressing 3OST-2. The values
were normalized against control cells (arbitrary value = 1). (C)
western blot analysis using an antibody against uncleaved caspase-
8, cleaved caspase-3, or Nanog. The histograms show mean
densitometric readings 6 SD after normalization against control
cells (arbitrary value = 1). **, P,0.05. Three independent
experiments were performed.
(TIF)
Table S1 List of gene specific primers for real time
PCR.
(TIF)
Table S2 List of gene specific probes for real time PCR.
(TIF)
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Figure 7. Subcellular localization of HS4C3-binding epitope and Fas, and scheme for Fas-mediated differentiation via HS4C3-
binding epitope. (A) Immunostaining, using HS4C3 and anti-Fas antibodies, of permeabilized mESCs in the presence of LIF (+LIF) or mESCs cultured
for 5 or 7 days in the absence of LIF (2LIF day 5 or day 7). Scale bar, 5 mm. Representative confocal images are shown. (B) Scheme for the induction of
differentiation by the activation of Fas signaling via the HS4C3-binding epitope. (1) The HS4C3-binding epitope is synthesized on HSPGs in the Golgi.
(2) The HS4C3-binding epitope on HSPGs interacts with Fas in the Golgi. (3) Fas then translocates into lipid rafts on the cell surface through
interaction between the HS4C3-binding epitope and Fas. Fas signaling is activated by this redistribution of Fas from the Golgi into the lipid rafts. (4)
Fas signaling activates caspase-3, and then activated caspase-3 degrades Nanog. (5) mESCs differentiate due to the degradation of Nanog. HSPGs,
heparan sulfate proteoglycans.
doi:10.1371/journal.pone.0043440.g007
HS4C3-Binding Epitope Contributes to Fas Signaling
PLOS ONE | www.plosone.org 14 August 2012 | Volume 7 | Issue 8 | e43440
References
1. Esko JD, Selleck SB (2002) Order out of chaos: assembly of ligand binding sites
in heparan sulfate. Annu Rev Biochem 71: 435–471.
2. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, et al. (1999)
Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:
729–777.
3. Lin X (2004) Functions of heparan sulfate proteoglycans in cell signaling during
development. Development 131: 6009–6021.
4. Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells
from mouse embryos. Nature 292: 154–156.
5. Martin GR (1981) Isolation of a pluripotent cell line from early mouse embryos
cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad
Sci U S A 78: 7634–7638.
6. Keller G (2005) Embryonic stem cell differentiation: emergence of a new era in
biology and medicine. Genes Dev 19: 1129–1155.
7. Chambers I, Smith A (2004) Self-renewal of teratocarcinoma and embryonic
stem cells. Oncogene 23: 7150–7160.
8. Boiani M, Scholer HR (2005) Regulatory networks in embryo-derived
pluripotent stem cells. Nat Rev Mol Cell Biol 6: 872–884.
9. Smith AG, Heath JK, Donaldson DD, Wong GG, Moreau J, et al. (1988)
Inhibition of pluripotential embryonic stem cell differentiation by purified
polypeptides. Nature 336: 688–690.
10. Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, et al. (1988) Myeloid
leukaemia inhibitory factor maintains the developmental potential of embryonic
stem cells. Nature 336: 684–687.
11. Niwa H, Burdon T, Chambers I, Smith A (1998) Self-renewal of pluripotent
embryonic stem cells is mediated via activation of STAT3. Genes Dev 12: 2048–
2060.
12. Niwa H (2007) How is pluripotency determined and maintained? Development
134: 635–646.
13. Chambers I, Colby D, Robertson M, Nichols J, Lee S, et al. (2003) Functional
expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem
cells. Cell 113: 643–655.
14. Ying QL, Nichols J, Chambers I, Smith A (2003) BMP induction of Id proteins
suppresses differentiation and sustains embryonic stem cell self-renewal in
collaboration with STAT3. Cell 115: 281–292.
15. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH (2004)
Maintenance of pluripotency in human and mouse embryonic stem cells
through activation of Wnt signaling by a pharmacological GSK-3-specific
inhibitor. Nat Med 10: 55–63.
16. Sasaki N, Okishio K, Ui-Tei K, Saigo K, Kinoshita-Toyoda A, et al. (2008)
Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells.
J Biol Chem 283: 3594–3606.
17. Miyabayashi T, Teo JL, Yamamoto M, McMillan M, Nguyen C, et al. (2007)
Wnt/b-catenin/CBP signaling maintains long-term murine embryonic stem cell
pluripotency. Proc Natl Acad Sci U S A 104: 5668–5673.
18. Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, et al.
(2007) FGF stimulation of the Erk1/2 signalling cascade triggers transition of
pluripotent embryonic stem cells from self-renewal to lineage commitment.
Development 134: 2895–2902.
19. Sasaki N, Hirano T, Ichimiya T, Wakao M, Hirano K, et al. (2009) The 39-
phosphoadenosine 59-phosphosulfate transporters, PAPST1 and 2, contribute to
the maintenance and differentiation of mouse embryonic stem cells. PLoS One
4: e8262.
20. Kraushaar DC, Yamaguchi Y, Wang L (2010) Heparan sulfate is required for
embryonic stem cells to exit from self-renewal. J Biol Chem 285: 5907–5916.
21. Lanner F, Lee KL, Sohl M, Holmborn K, Yang H, et al. (2010) Heparan
sulfation-dependent fibroblast growth factor signaling maintains embryonic stem
cells primed for differentiation in a heterogeneous state. Stem Cells 28: 191–200.
22. Johnson CE, Crawford BE, Stavridis M, Ten Dam G, Wat AL, et al. (2007)
Essential alterations of heparan sulfate during the differentiation of embryonic
stem cells to Sox1-enhanced green fluorescent protein-expressing neural
progenitor cells. Stem Cells 25: 1913–1923.
23. Baldwin RJ, ten Dam GB, van Kuppevelt TH, Lacaud G, Gallagher JT, et al.
(2008) A developmentally regulated heparan sulfate epitope defines a
subpopulation with increased blood potential during mesodermal differentiation.
Stem Cells 26: 3108–3118.
24. Ten Dam GB, Kurup S, van de Westerlo EM, Versteeg EM, Lindahl U, et al.
(2006) 3-O-sulfated oligosaccharide structures are recognized by anti-heparan
sulfate antibody HS4C3. J Biol Chem 281: 4654–4662.
25. Mochizuki H, Yoshida K, Shibata Y, Kimata K (2008) Tetrasulfated
disaccharide unit in heparan sulfate: enzymatic formation and tissue
distribution. J Biol Chem 283: 31237–31245.
26. Xia G, Chen J, Tiwari V, Ju W, Li JP, et al. (2002) Heparan sulfate 3-O-
sulfotransferase isoform 5 generates both an antithrombin-binding site and an
entry receptor for herpes simplex virus, type 1. J Biol Chem 277: 37912–37919.
27. Kamiyama S, Sasaki N, Goda E, Ui-Tei K, Saigo K, et al. (2006) Molecular
cloning and characterization of a novel 39-phosphoadenosine 59-phosphosulfate
transporter, PAPST2. J Biol Chem 281: 10945–10953.
28. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC (1993) Derivation
of completely cell culture-derived mice from early-passage embryonic stem cells.
Proc Natl Acad Sci U S A 90: 8424–8428.
29. Smith AG, Hooper ML (1987) Buffalo rat liver cells produce a diffusible activity
which inhibits the differentiation of murine embryonal carcinoma and
embryonic stem cells. Dev Biol 121: 1–9.
30. Smits NC, Lensen JF, Wijnhoven TJ, Ten Dam GB, Jenniskens GJ, et al. (2006)
Phage display-derived human antibodies against specific glycosaminoglycan
epitopes. Methods Enzymol 416: 61–87.
31. van Kuppevelt TH, Dennissen MA, van Venrooij WJ, Hoet RM, Veerkamp JH
(1998) Generation and application of type-specific anti-heparan sulfate
antibodies using phage display technology. Further evidence for heparan sulfate
heterogeneity in the kidney. J Biol Chem 273: 12960–12966.
32. Bennett M, Macdonald K, Chan SW, Luzio JP, Simari R, et al. (1998) Cell
surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science
282: 290–293.
33. Ko YG, Lee JS, Kang YS, Ahn JH, Seo JS (1999) TNF-alpha-mediated
apoptosis is initiated in caveolae-like domains. J Immunol 162: 7217–7223.
34. Legembre P, Moreau P, Daburon S, Moreau JF, Taupin JL (2002) Potentiation
of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked
Fas. Cell Death Differ 9: 329–339.
35. Schuck S, Honsho M, Ekroos K, Shevchenko A, Simons K (2003) Resistance of
cell membranes to different detergents. Proc Natl Acad Sci U S A 100: 5795–
5800.
36. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, et al. (2002) Post-
translational disruption of dystroglycan-ligand interactions in congenital
muscular dystrophies. Nature 418: 417–422.
37. Duval D, Malaise M, Reinhardt B, Kedinger C, Boeuf H (2004) A p38 inhibitor
allows to dissociate differentiation and apoptotic processes triggered upon LIF
withdrawal in mouse embryonic stem cells. Cell Death Differ 11: 331–341.
38. Fujita J, Crane AM, Souza MK, Dejosez M, Kyba M, et al. (2008) Caspase
activity mediates the differentiation of embryonic stem cells. Cell Stem Cell 2:
595–601.
39. Gajate C, Del Canto-Janez E, Acuna AU, Amat-Guerri F, Geijo E, et al. (2004)
Intracellular triggering of Fas aggregation and recruitment of apoptotic
molecules into Fas-enriched rafts in selective tumor cell apoptosis. J Exp Med
200: 353–365.
40. Schutze S, Tchikov V, Schneider-Brachert W (2008) Regulation of TNFR1 and
CD95 signalling by receptor compartmentalization. Nat Rev Mol Cell Biol 9:
655–662.
41. Ivanov VN, Lopez Bergami P, Maulit G, Sato TA, Sassoon D, et al. (2003) FAP-
1 association with Fas (Apo-1) inhibits Fas expression on the cell surface. Mol
Cell Biol 23: 3623–3635.
42. Villena J, Mainez J, Noguer O, Contreras H, Granes F, et al. (2006) Syndecan-2
expression increases serum-withdrawal-induced apoptosis, mediated by re-
distribution of Fas into lipid rafts, in stably transfected Swiss 3T3 cells. Apoptosis
11: 2065–2075.
43. Brunlid G, Pruszak J, Holmes B, Isacson O, Sonntag KC (2007) Immature and
neurally differentiated mouse embryonic stem cells do not express a functional
Fas/Fas ligand system. Stem Cells 25: 2551–2558.
HS4C3-Binding Epitope Contributes to Fas Signaling
PLOS ONE | www.plosone.org 15 August 2012 | Volume 7 | Issue 8 | e43440
